Chronic Idiopathic Constipation (CIC) Clinical Trials

Find Chronic Idiopathic Constipation (CIC) Clinical Trials Near You

Effectiveness of Daily Supplementation of a Fiber Nutritional Supplement (Materna® Opti-fiber) and Counselling for Constipation Management in Pregnancy

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to evaluate the effectiveness of a daily Fiber Nutritional Supplement (Materna® Opti fiber), containing partially hydrolyzed guar gum (PHGG) and vitamins C, D, zinc, and selenium, combined with nutritional counselling, for the management of constipation during pregnancy. Constipation is a common gastrointestinal complaint in pregnancy and may negatively affect quality of life and well being. The study is designed as an open label, single arm intervention conducted in pregnant women between 13 and 27 weeks of gestation who meet the Cullen 2007 criteria for functional constipation. A total of 31 participants are planned for enrolment. Eligible participants will receive one sachet per day of the Fiber Nutritional Supplement (Materna® Opti fiber), providing approximately 5.8 g of PHGG, for a duration of 4 weeks. In addition to the investigational product, all participants will receive standardized constipation counselling at baseline, including education on constipation, lifestyle measures.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 21
Healthy Volunteers: t
View:

• Pregnant women aged 21 years-old or above at recruitment

• Gestational age of 13-27 weeks at recruitment

• Singleton pregnancy at recruitment

• Suffering from functional constipation according to the Cullen 2007 criteria which must include ALL the following and the criteria must be fulfilled for at least two weeks with symptom onset during pregnancy:

‣ Low frequency of stool (\<3/week)

⁃ Hard stools

⁃ Difficulty on evacuation

• Able to understand and to sign a written Informed Consent Form (ICF) prior to study enrolment.

• Willing and able to comply with the requirements for participation in this study

• Willing and able to refrain from consuming other supplements containing fiber, prebiotics, or probiotics other than the Fiber Nutritional Supplement (Materna® Opti-fiber) over the intervention period

• Able to respond to questionnaires in English

Locations
Other Locations
Brazil
Medcin Pesquisa Clínica
RECRUITING
Osasco
Contact Information
Primary
Alison Iroz, PhD
alison.petit-jean@nestle.com
+44763720486
Backup
Irma Silva Zolezzi, PhD
Irma.SilvaZolezzi@nestle.com
Time Frame
Start Date: 2026-05-08
Estimated Completion Date: 2026-10-08
Participants
Target number of participants: 31
Treatments
Experimental: Interventional
Fiber Nutritional Supplement with constipation counselling
Related Therapeutic Areas
Sponsors
Leads: Société des Produits Nestlé (SPN)

This content was sourced from clinicaltrials.gov